<DOC>
	<DOC>NCT02756546</DOC>
	<brief_summary>This study aims to identify the expression signature of miR-181a, miR-196a and miR-21 in plasma of SLE patients and difference in their expression among groups with different systemic lupus erythematosis disease activity index (SLEDAI) scores.</brief_summary>
	<brief_title>Circulating MicroRNAs in Understanding Pathogenesis of Systemic Lupus Erythematosis</brief_title>
	<detailed_description />
	<mesh_term>Lupus Erythematosus, Systemic</mesh_term>
	<mesh_term>Cyclophosphamide</mesh_term>
	<mesh_term>Hydroxychloroquine</mesh_term>
	<mesh_term>Hydrocortisone 17-butyrate 21-propionate</mesh_term>
	<mesh_term>Cortisol succinate</mesh_term>
	<mesh_term>Hydrocortisone acetate</mesh_term>
	<mesh_term>Hydrocortisone</mesh_term>
	<criteria>Adult systemic lupus erythematosis patients Patients younger than 18 years, patients with other autoimmune diseases or malignancy.</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>April 2016</verification_date>
</DOC>